Key role of P38 mitogen-activated protein kinase and the lipoxygenase pathway in angiotensin II actions in H295R adrenocortical cells
- PMID: 12450322
- DOI: 10.1385/ENDO:18:3:295
Key role of P38 mitogen-activated protein kinase and the lipoxygenase pathway in angiotensin II actions in H295R adrenocortical cells
Abstract
Angiotensin II (ANG II) can activate the mitogen-activated protein kinases (MAPKs) and stress-activated protein kinases in several cell types. We have previously shown that the 12-lipoxygenase (12-LO) pathway of arachidonic acid metabolism is a mediator of ANG II-induced aldosterone synthesis in adrenal glomerulosa cells. To evaluate the role of MAPK activation in ANG II and the effects of LO on aldosterone synthesis, experiments were performed using the human adrenocortical cell line H295R, which secretes aldosterone in response to ANG II. MAPK activities were determined by Western immunoblotting using specific antibodies to their activated phosphorylated forms. ANG II led to a dose-dependent increase in extracellular signal-regulated kinase (ERK1/2) activity in these cells, with a peak at 5 min and lasting up to 3 h. The effects of ANG II were blocked by the ANG-II Type 1 receptor antagonist losartan. A specific 12-LO product, 12(S)-hydroxyeicosatetraenoic acid (12-HETE), had no direct effect on ERK activity. However, both ANG II and 12-HETE led to significant dose-dependent increases in p38 MAPK activity with peak effects at 5 min. By contrast, the 15-LO product, 15-HETE, had no effect on p38 MAPK activity. Furthermore, two dissimilar 12-LO inhibitors, CDC and baicalein, blocked ANG II-induced p38 MAPK activation. ANG II significantly increased aldosterone release, and this effect was inhibited by the LO inhibitor baicalein, as well as a specific p38 MAPK inhibitor, SB202190, but not by PD098059, a specific inhibitor of the ERK activator MEK. In summary, in H295R cells, ANG II activated ERK and p38 MAPKs, ANG II-induced p38 MAPK was mediated by 12-LO activation, and ANG II-induced aldosterone synthesis was prevented by 12-LO- and p38 MAPK-specific inhibitors. These results suggest, for the first time, that activation of p38 MAPK, either directly or via LO activation, participates in aldosterone's stimulatory effects of ANG II in adrenal cells.
Similar articles
-
12-lipoxygenase pathway increases aldosterone production, 3',5'-cyclic adenosine monophosphate response element-binding protein phosphorylation, and p38 mitogen-activated protein kinase activation in H295R human adrenocortical cells.Endocrinology. 2003 Feb;144(2):534-43. doi: 10.1210/en.2002-220580. Endocrinology. 2003. PMID: 12538614
-
Interaction of MAPK and 12-lipoxygenase pathways in growth and matrix protein expression in mesangial cells.Am J Physiol Renal Physiol. 2002 Nov;283(5):F985-94. doi: 10.1152/ajprenal.00181.2002. Am J Physiol Renal Physiol. 2002. PMID: 12372774
-
The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects.J Biol Chem. 2002 Mar 22;277(12):9920-8. doi: 10.1074/jbc.M111305200. Epub 2002 Jan 10. J Biol Chem. 2002. PMID: 11786549
-
Role of MAPKs in angiotensin II-induced steroidogenesis in rat glomerulosa cells.Mol Cell Endocrinol. 2007 Feb;265-266:126-30. doi: 10.1016/j.mce.2006.12.008. Epub 2007 Jan 9. Mol Cell Endocrinol. 2007. PMID: 17215073 Review.
-
[Behavioral and Molecular Pharmacological Study of the Role of Angiotensin II in Spinal Pain Transmission].Yakugaku Zasshi. 2018;138(10):1235-1240. doi: 10.1248/yakushi.18-00124. Yakugaku Zasshi. 2018. PMID: 30270265 Review. Japanese.
Cited by
-
VLDL-activated cell signaling pathways that stimulate adrenal cell aldosterone production.Mol Cell Endocrinol. 2016 Sep 15;433:138-46. doi: 10.1016/j.mce.2016.05.018. Epub 2016 May 21. Mol Cell Endocrinol. 2016. PMID: 27222295 Free PMC article.
-
Eliminating or blocking 12/15-lipoxygenase reduces neutrophil recruitment in mouse models of acute lung injury.Crit Care. 2012 Sep 13;16(5):R166. doi: 10.1186/cc11518. Crit Care. 2012. PMID: 22973824 Free PMC article.
-
New insights into signal transduction pathways in adrenal steroidogenesis: role of mitochondrial fusion, lipid mediators, and MAPK phosphatases.Front Endocrinol (Lausanne). 2023 May 8;14:1175677. doi: 10.3389/fendo.2023.1175677. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37223023 Free PMC article. Review.
-
Improved survival and reduced vascular permeability by eliminating or blocking 12/15-lipoxygenase in mouse models of acute lung injury (ALI).J Immunol. 2009 Oct 1;183(7):4715-22. doi: 10.4049/jimmunol.0802592. Epub 2009 Sep 14. J Immunol. 2009. PMID: 19752233 Free PMC article.
-
12-lipoxygenase: a potential target for novel anti-platelet therapeutics.Cardiovasc Hematol Agents Med Chem. 2011 Jul 1;9(3):154-64. doi: 10.2174/187152511797037619. Cardiovasc Hematol Agents Med Chem. 2011. PMID: 21838667 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous